6th Next-Generation Histone Deacetylase Inhibitors
1st to 2nd October 2012
Boston, MA, United States of America
Contact person: Dave Mello
"Targeting HDACs for Oncology, Inflammation, CNS and Other Therapeutic Indications" Cutting-Edge Research from Sloan-Kettering, Broad Institute, McGill, Mass General Scripps, Dana-Farber, UPenn, Duke, & Many More.
Check the event website for more details.